AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease

Aaron K F Wong1, Jacqueline Howie, John R Petrie

  • 1Division of Medicine and Therapeutics, University of Dundee and Medical School, Ninewells Hospital, Dundee DD1 9SY, Scotland, UK.

Insights

AMP-activated protein kinase (AMPK) regulates energy balance and is crucial for heart function during stress. Targeting AMPK offers potential therapeutic strategies for cardiovascular and metabolic diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cardiovascular Physiology

Background:

  • AMP-activated protein kinase (AMPK) is a key enzyme regulating cellular energy homeostasis.
  • AMPK activation is triggered by metabolic stresses like anoxia, ischemia, and fasting, crucial for maintaining ATP levels.
  • AMPK plays a vital role in cardiac function during ischemic events, preserving myocardial viability.

Purpose of the Study:

  • To review the role of AMPK in energy homeostasis and cardiovascular pathophysiology.
  • To explore the upstream and downstream signaling pathways regulating AMPK.
  • To highlight the therapeutic potential of targeting AMPK for cardiometabolic diseases.

Main Methods:

  • Literature review of AMPK's role in cellular energy metabolism.
  • Analysis of AMPK's involvement in cardiovascular and metabolic disease mechanisms.
  • Examination of AMPK's interaction with upstream kinases (LKB1, CaMK) and downstream targets (eEF2 kinase, p70 S6 kinase).

Main Results:

  • AMPK activation sustains ATP levels and cardiac function during ischemia.
  • AMPK signaling pathways are implicated in glucose metabolism, fatty acid oxidation, and protein synthesis.
  • AMPK is involved in the mechanism of action of drugs like metformin, thiazolidinediones, and statins.

Conclusions:

  • AMPK is a central regulator of energy balance with significant implications in cardiovascular and metabolic diseases.
  • Understanding AMPK activation and its signaling network is crucial for developing novel therapeutic strategies.
  • Targeting AMPK presents a promising avenue for treating conditions such as cardiac ischemia, arrhythmias, and hypertrophy.

Related Concept Videos

cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...